PPP1R32: A Protein Target for A Variety of Diseases (G220004)

Target Name: PPP1R32

NCBI ID: G220004

PPP1R32

PPP1R32: A Protein Target for A Variety of Diseases

PPP1R32 (FLJ32771) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its primary function is to regulate the activity of the protein PPAR未, which is a key regulator of inflammation and cellular signaling.

Recent studies have identified PPP1R32 as a potential drug target for the treatment of various diseases, including diabetes, heart disease, and neurodegenerative disorders. This is because PPP1R32 has been shown to play a role in modulating the activity of PPAR未, which is involved in the regulation of cellular processes that are central to the development and progression of many diseases.

One of the key reasons for the potential of PPP1R32 as a drug target is its broad specificity. While it is true that PPP1R32 is a protein that is involved in the regulation of PPAR未, there is evidence to suggest that it may have a more general role in the regulation of cellular processes that are relevant to many diseases. This is because PPP1R32 is highly conserved, meaning that it is highly similar from one species to another, and is found in a wide variety of organisms.

This broad specificity is important because it allows researchers to use PPP1R32 as a potential drug target in a variety of different diseases. For example, because PPP1R32 is involved in the regulation of PPAR未, it may be a useful target for the treatment of diseases that are caused by the activation of PPAR未. This could include diseases such as diabetes, heart disease, and neurodegenerative disorders.

In addition to its potential as a drug target, PPP1R32 is also a potential biomarker for the diagnosis and progression of various diseases. This is because it is often expressed at relatively high levels in certain tissues, and can be used as a protein biomarker for the detection and quantification of diseases. For example, researchers have used PPP1R32 as a biomarker for the diagnosis of neurodegenerative disorders, and have shown that it is often decreased in these diseases.

Overall, PPP1R32 is a protein that has the potential to be a drug target and biomarker for the treatment of a wide variety of diseases. While more research is needed to fully understand its role and to develop effective treatments, its broad specificity and potential as a drug target make it an promising target for further investigation.

Protein Name: Protein Phosphatase 1 Regulatory Subunit 32

The "PPP1R32 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PPP1R32 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets